BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 30440155)

  • 1. [Clinical features of glucocorticoid eye drops induced ocular hypertension in pediatric and adult uveitic eyes].
    Pei MH; Zhao C; Gao F; Zhang MF
    Zhonghua Yan Ke Za Zhi; 2018 Nov; 54(11):839-842. PubMed ID: 30440155
    [No Abstract]   [Full Text] [Related]  

  • 2. Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Sallam A; Sheth HG; Habot-Wilner Z; Lightman S
    Am J Ophthalmol; 2009 Aug; 148(2):207-213.e1. PubMed ID: 19403113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pattern of intraocular pressure fluctuation in uveitic eyes treated with corticosteroids.
    Shrestha S; Thapa M; Shah DN
    Ocul Immunol Inflamm; 2014 Apr; 22(2):110-5. PubMed ID: 24131295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of Ocular Hypertension in Adults with Noninfectious Uveitis.
    Daniel E; Pistilli M; Kothari S; Khachatryan N; Kaçmaz RO; Gangaputra SS; Sen HN; Suhler EB; Thorne JE; Foster CS; Jabs DA; Nussenblatt RB; Rosenbaum JT; Levy-Clarke GA; Bhatt NP; Kempen JH;
    Ophthalmology; 2017 Aug; 124(8):1196-1208. PubMed ID: 28433444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased intraocular pressure during treatment for chronic uveitis.
    BenEzra D; Wysenbeek YS; Cohen E
    Graefes Arch Clin Exp Ophthalmol; 1997 Apr; 235(4):200-3. PubMed ID: 9143886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical outcomes in childhood uveitic glaucoma.
    Bohnsack BL; Freedman SF
    Am J Ophthalmol; 2013 Jan; 155(1):134-42. PubMed ID: 23036573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with intraocular pressure increase in patients with uveitis treated with the fluocinolone acetonide implant.
    Parekh A; Srivastava S; Bena J; Albini T; Nguyen QD; Goldstein DA
    JAMA Ophthalmol; 2015 May; 133(5):568-73. PubMed ID: 25719937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Intraocular Pressure Elevation in Pediatric Noninfectious Uveitis.
    Kothari S; Foster CS; Pistilli M; Liesegang TL; Daniel E; Sen HN; Suhler EB; Thorne JE; Jabs DA; Levy-Clarke GA; Nussenblatt RB; Rosenbaum JT; Lawrence SD; Kempen JH;
    Ophthalmology; 2015 Oct; 122(10):1987-2001. PubMed ID: 26233626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical dexamethasone-cyclodextrin nanoparticle eye drops for non-infectious Uveitic macular oedema and vitritis - a pilot study.
    Shulman S; Jóhannesson G; Stefánsson E; Loewenstein A; Rosenblatt A; Habot-Wilner Z
    Acta Ophthalmol; 2015 Aug; 93(5):411-415. PubMed ID: 25988730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of Ocular Steroid Hypertensive Response in Children.
    Kaur S; Dhiman I; Kaushik S; Raj S; Pandav SS
    J Glaucoma; 2016 Apr; 25(4):343-7. PubMed ID: 25651206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Cataract Development among Children with Juvenile Idiopathic Arthritis-Related Uveitis Treated with Topical Corticosteroids.
    Thorne JE; Woreta FA; Dunn JP; Jabs DA
    Ophthalmology; 2020 Apr; 127(4S):S21-S26. PubMed ID: 32200821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of ripasudil, a Rho-associated kinase inhibitor, in eyes with uveitic glaucoma.
    Kusuhara S; Katsuyama A; Matsumiya W; Nakamura M
    Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):809-814. PubMed ID: 29468405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and potential complications of difluprednate use for pediatric uveitis.
    Slabaugh MA; Herlihy E; Ongchin S; van Gelder RN
    Am J Ophthalmol; 2012 May; 153(5):932-8. PubMed ID: 22265149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxoplasmosis retinochoroiditis and elevated intraocular pressure: a retrospective study.
    Westfall AC; Lauer AK; Suhler EB; Rosenbaum JT
    J Glaucoma; 2005 Feb; 14(1):3-10. PubMed ID: 15650597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of ocular hypertension in children treated with systemic glucocorticoid.
    Krag S; Larsen D; Albertsen BK; Glerup M
    Acta Ophthalmol; 2021 Dec; 99(8):e1430-e1434. PubMed ID: 33629533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Outcome of raised intraocular pressure in uveitic eyes with and without a corticosteroid-induced hypertensive response.
    Nazm N; Dubey S; Gandhi M; Pegu J
    Am J Ophthalmol; 2010 Mar; 149(3):525-6; author reply 526-7. PubMed ID: 20172078
    [No Abstract]   [Full Text] [Related]  

  • 18. Steroid-induced ocular hypertension in the pediatric age group.
    Al Hanaineh AT; Hassanein DH; Abdelbaky SH; El Zawahry OM
    Eur J Ophthalmol; 2018 Jul; 28(4):372-377. PubMed ID: 29554813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of steroid induced-ocular hypertension in postoperative pterygium excision.
    Makornwattana M; Suphachearaphan W
    J Med Assoc Thai; 2015 Mar; 98 Suppl 2():S151-7. PubMed ID: 26211117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of 2% ganciclovir eye drops on cytomegalovirus positive Posner-Schlossman syndrome].
    Zhai RY; Xu H; Kong XM; Wang ZJ
    Zhonghua Yan Ke Za Zhi; 2018 Nov; 54(11):833-838. PubMed ID: 30440154
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.